Samuel Sarkodie Professor James Wason Dr Michael Grayling
| A hybrid approach to sample size re-estimation in cluster randomized trials with continuous outcomes | 2024 |
|
Professor Andrew Fisher Professor Helen Hancock Professor James Wason Dr Michael Grayling Dr Joanne Lally et al. | Extracorporeal Photopheresis (ECP) in the Treatment of Chronic Lung Allograft Dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK) | 2024 |
|
Dr Svetlana Cherlin Dr Theophile Bigirumurame Dr Michael Grayling Dr Jérémie Nsengimana Luke Ouma et al. | Utilising high-dimensional data in randomised clinical trials: a review of methods and practice | 2024 |
|
Dr Michael Grayling Sylvia Zhang
| A Bayesian approach to pilot-pivotal trials for bioequivalence assessment | 2023 |
|
Samuel Sarkodie Professor James Wason Dr Michael Grayling
| A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation | 2023 |
|
Andrew Bryant Dr Michael Grayling Professor Dawn Craig Professor Luke Vale
| Residual Disease after Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias | 2023 |
|
Andrew Bryant Eugenie Johnson Dr Michael Grayling Shaun Hiu Dr Ahmed Elattar et al. | Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis | 2023 |
|
Dr Heather Lambert Shaun Hiu Dr Malcolm Coulthard Professor John Matthews Dr Eva-Maria Holstein et al. | The Infant KIdney Dialysis and Utrafiltration (I-KID) Study: A Stepped-Wedge Cluster-Randomized Study in Infants, Comparing Peritoneal Dialysis, Continuous Venovenous Hemofiltration, and Newcastle Infant Dialysis Ultrafiltration System, a Novel Infant Hemodialysis Device | 2023 |
|
Dr Michele Castelli Dr Michael Grayling
| The prevalence and social determinants of multimorbidity in South Africa | 2023 |
|
Luke Ouma Dr Michael Grayling Professor James Wason Dr Haiyan Zheng
| Bayesian modelling strategies for borrowing of information in randomised basket trials | 2022 |
|
Dr Michael Grayling Professor Rakesh Heer Professor James Wason
| Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials | 2022 |
|
Dr Michael Grayling
| Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials | 2022 |
|
Andrew Bryant Dr Michael Grayling Shaun Hiu Eugenie Johnson Professor Luke Vale et al. | Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis | 2022 |
|
Dr Faye Williamson Dr Michael Grayling Professor James Wason
| Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information | 2022 |
|
Aritra Mukherjee Professor James Wason Dr Michael Grayling
| When is a two-stage single-arm trial efficient? An evaluation of the impact of outcome delay | 2022 |
|